Drug recall
Uprizing 2.0 (13-ethyl-3-methoxy-gona-2,5(10),-dien-17-one 30 mg…
FDA recall event 59836 · Class I · Superior Metabolic Technologies
Key facts
| Event ID | 59836 |
|---|---|
| Recall numbers | D-864-2012 |
| Recalling firm | Superior Metabolic Technologies |
| Product type | Drugs |
| Products | Uprizing 2.0 (13-ethyl-3-methoxy-gona-2,5(10),-dien-17-one 30 mg; 4-Chloro-17a-Methyl-Androsta-1,4-diene-3,17-diol 17.5 mg; 2a 17a dimethyl etiocholan 3, one 17b-ol 10 mg) capsules, 90-count capsules… |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Marketed Without an Approved NDA/ANDA: FDA analysis found the product to contain a synthetic steroid, making Uprizing 2.0 capsules an unapproved new drug. |
| Initiation date | Aug 5, 2011 |
| Termination date | Aug 12, 2013 |
| City | Kennesaw |
| State | GA |
| Country | United States |
| FEI number | 3009082985 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports